Exploring Artificial Intelligence in Drug Discovery - MarketScale
... risks of AI's “black box” nature. Crown BioScience is developing internal AI frameworks to transform data into insights, optimize experimental ...
Read the original at MarketScale ↗
- Topics
- Governance & Risk Management
- Tracked via
- “AI Risks”